Shares in pharmaceuticals giant GlaxoSmithKline gained after the the US FDA approved Breo Ellipta, the company's treatme...
SUBSCRIBE TO OUR NEWSLETTER
Get the latest news from IFA Magazine
Quick Links
News
Archive
IFA Magazine
Copyright © 2013 IFA Magazine.
For today's discerning financial and investment professional.
Terms | Privacy | Contact Us | Sitemap
Copyright © 2013 IFA Magazine.
For today's discerning financial and investment professional.
Terms | Privacy | Contact Us | Sitemap




